Skip to main content
Medical information Clinical review pending

Infection Testing

Measles Virus Viral Load Quantitative Test

Measures the amount of measles virus in the body using Real Time PCR. Helps monitor infection severity and guide treatment decisions.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Serum, plasma, whole blood, urine, cerebrospinal fluid (C.S.F.), oral swabs, or bronchial swabs.
Results
Confirm with the laboratory before booking. Typically available within 36 hours via email or 24 hours via phone.
Preparation
Confirm with the laboratory before booking. Provide relevant clinical history and sign a consent document.
Test priceKSh 19,720

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Measles Virus Viral Load Quantitative Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Suspected measles infection
  • ✓Monitoring treatment response
  • ✓Assessing infection severity
  • ✓Individuals with weakened immune systems
  • ✓Epidemiological investigations
  • ✓Diagnosis in complex cases
02

In plain language

What this test helps you understand

Quantifies the amount of measles virus in the body to assess infection severity, monitor disease progression, and guide treatment decisions, particularly in immunocompromised individuals or those with severe symptoms.
The Measles Virus Viral Load Quantitative Test is a diagnostic tool used to measure the quantity of measles virus present in a patient's body. This test is particularly useful for monitoring individuals with measles, especially those experiencing severe symptoms or who have weakened immune systems. Understanding the viral load helps healthcare providers make informed decisions about managing and treating the infection.

This test quantifies the measles virus in samples like serum, plasma, whole blood, urine, cerebrospinal fluid (C.S.F.), oral swabs, and bronchial swabs. It uses the Real Time PCR method, known for its accuracy in detecting viral RNA.

Individuals showing measles symptoms (high fever, cough, runny nose, rash), those exposed to confirmed cases, or individuals with health conditions that might worsen with measles should consider this test. It provides valuable information for assessing infection severity, guiding treatment, monitoring patients, and tracking therapy effectiveness.

Results are typically available within 36 hours via email or 24 hours via phone. Discuss your results with your healthcare provider for proper interpretation.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm with the laboratory before booking. Provide relevant clinical history and sign a consent document.
SampleSerum, plasma, whole blood, urine, cerebrospinal fluid (C.S.F.), oral swabs, or bronchial swabs.
MethodologyReal Time PCR (Polymerase Chain Reaction)
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects the presence and quantity of measles virus RNA. Results should be interpreted alongside clinical findings and other diagnostic tests. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test measures the amount (viral load) of the measles virus in a sample taken from your body.
It helps doctors understand how severe the measles infection is, monitor how well treatment is working, and make informed decisions about patient care.
Samples can include blood, urine, cerebrospinal fluid, or swabs from the mouth or airways.
Results are typically available within 36 hours via email or 24 hours via phone. Confirm with the laboratory before booking.
People with symptoms of measles, those exposed to measles, or individuals with health conditions that could make measles more serious should discuss this test with their doctor.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp